AccessMyLibrary provides FREE access to over 30 million articles from top publications available through your library.
Close
Create a link to this page
Copy and paste this link tag into your Web page or blog:
<a href="http://www.accessmylibrary.com/article-1G1-169982467/verona-rpl554-enters-toxicology.html" title="Facts and information about Verona's RPL554 enters toxicology study.(Verona Pharma Plc.)(Brief article)">Verona's RPL554 enters toxicology study.(Verona Pharma Plc.)(Brief article)</a>
Close
Set up an RSS feed that alerts you when new articles from Pharma Marketletter are available.
Frequently asked questions about RSS feeds
Verona's RPL554 enters toxicology study.(Verona Pharma Plc.)(Brief article)
UK-based Verona Pharma says that its novel anti-asthmatic compound, RPL554, is now entering a 28-day experimental inhalation toxicology study to demonstrate safety, before moving onto a proof-of-concept clinical trials early next year.
Verona Pharma adds that it is aiming to exploit a major opportunity in the $20.0 billion respiratory market with this compound, noting that many of today's drugs for asthma have unwanted side-effects and/or limited effectiveness.
RPL554 was invented by Sir ...
Related articles from newspapers, magazines, journals, and more
For more facts and information, see all results
- Verona Pharma plc.(Other News To Note)
- Newspaper article from: BioWorld International November 14, 2007 700+ words
Verona Pharma plc, of London, said its asthma drug candidate, RPL554, is starting a second 28-day inhalation toxicology study to demonstrate safety, and pending positive results, the company anticipates moving into the clinic early next...
- AIM-Quoted Verona Pharma Progresses Anti-Asthma Drug Studies.
- Press release article from: PR Newswire November 6, 2007 700+ words
...discovery company Verona Pharma is pleased to announce...experimental inhalation toxicology study in another species...limited effectiveness. Verona Pharma is aiming to exploit...drugs already in use. Verona Pharma has acquired the intellectual...
- Verona Pharma Signs Deal to Start Pre-clinical Studies on Ground Breaking Hay...
- Press release article from: PR Newswire June 4, 2007 700+ words
...FirstCall/ -- The life-sciences company Verona Pharma plc., has signed a contract with LAB Research...creating a medical need in this market that Verona Pharma is working to meet. Verona Pharma's CEO, Professor Michael Walker, commented...
- SemBioSys initiates toxicology study for safflower-produced insulin.
- Press release article from: PR Newswire March 26, 2008 700+ words
...announced that it has initiated a toxicology study in animals to demonstrate the safety...study in monkeys and rats is the only toxicology study required before submission of the...SemBioSys. "In order to start the toxicology study we had to demonstrate that our safflower...
- Verona Pharma PLC - Company Secretary Appointment.
- News wire article from: Europe Intelligence Wire October 2, 2006 700+ words
(From AFX CNF) RNS Number:7814J Verona Pharma PLC 02 October 2006 Verona Pharma Plc - Change of Company Secretary and Registered Office Verona Pharma plc announces the appointment of John Bottomley as company secretary. In addition, the registered...
- Verona Pharma PLC - Interim Results.
- News wire article from: Europe Intelligence Wire September 29, 2006 700+ words
(From AFX CNF) RNS Number:6897J Verona Pharma PLC 29 September 2006 VERONA PHARMA PLC (Formerly known as ISIS RESOURCES PLC...is with pleasure that I join the Board of Verona Pharma plc (the "Company") as Chairman following...
- ANA975 in a New 13-Week Pre-Clinical Toxicology Study Using Crystalline Form.
- Press release article from: PR Newswire November 7, 2006 700+ words
...a new 13-week pre-clinical toxicology study of ANA975 to assess safety and tolerability...occurred in the initial 13-week toxicology study in animals," said Steve Worland...clinical trials and whether the new toxicology study will provide information necessary...
- ARIUS announces cancer stem cell antibody program successfully completes first...
- Press release article from: PR Newswire October 23, 2007 700+ words
...has successfully completed its first toxicology study and has shown good efficacy in animal...successfully completed our initial CD44 toxicology study, we look forward to moving our CD44...human tumors. A dose-ranging pilot toxicology study in non-human primate models demonstrated...
- Verona Pharma H1 pretax loss widens on higher R&D costs.
- News wire article from: Europe Intelligence Wire September 23, 2008 700+ words
(From AFX UK (Focus)) LONDON (Thomson Financial) - Verona Pharma Plc., the AIM-quoted respiratory disease specialist...projects of interest. For the six months to end-June, Verona Pharma posted a pretax loss of 637,926 pounds from 457,638 pounds...
- Verona Pharma PLC - Holding(s) in Company.
- News wire article from: Europe Intelligence Wire October 2, 2006 700+ words
(From AFX CNF) RNS Number:7946J Verona Pharma PLC 02 October 2006 Verona Pharma plc (the "Company") Holding(s) in Company The Company received notification on 26 September 2006 that FMR Corp and Fidelity International Limited have an...
Source: HighBeam Research, Verona's RPL554 enters toxicology study.(Verona Pharma Plc.)(Brief...